Circulation, Vol 82, 1424-1437, Copyright © 1990 by American Heart Association
AJ Sinusas, KA Trautman, JD Bergin, DD Watson, M Ruiz, WH Smith and GA Beller
Serial myocardial imaging with technetium-99m methoxyisobutyl isonitrile
(99mTc-MIBI) has been proposed for evaluating myocardial salvage after
reperfusion. To define 99mTc-MIBI uptake before and after reperfusion, 17
open-chest dogs underwent 3 hours of left anterior descending artery
occlusion and 3 hours of reperfusion. 99mTc-MIBI was injected during
occlusion (group 1) or after 90 minutes of reperfusion (group 2).
Myocardial 99mTc-MIBI activity was correlated with microsphere flow during
occlusion and reperfusion. Anatomic risk area and infarct area were defined
by postmortem vital staining and correlated with the perfusion defects
defined by analysis of 99mTc-MIBI macroautoradiographs and gamma camera
images of myocardial slices. The left ventricle was divided into 96
segments for gamma well counting. Flow and 99mTc-MIBI activity were
normalized to nonischemic values. Myocardial segments were grouped, based
on occlusion flow, into zones: severely ischemic (less than or equal to 30%
nonischemic), moderately ischemic (greater than 30%, less than or equal to
60% nonischemic), mildly ischemic (greater than 60%, less than or equal to
90% nonischemic), and nonischemic (greater than 90%, less than or equal to
120% nonischemic). Among dogs injected with 99mTc-MIBI during coronary
occlusion (group 1), myocardial 99mTc-MIBI activity correlated linearly
with occlusion flow for both endocardial (r = 0.91) and transmural (r =
0.91) segments. The risk area defined by 99mTc-MIBI autoradiography (group
1) correlated with the postmortem risk area (rho = 0.94) but was 29%
smaller than the anatomic risk area (p = 0.03), reflecting the contribution
of collateral flow. Among dogs injected with 99mTc-MIBI after reperfusion
(group 2), myocardial 99mTc-MIBI did not correlate with reperfusion flow in
either endocardial or transmural segments. Among group 2 dogs, myocardial
99mTc-MIBI activity was significantly less than reperfusion flow at the
time of injection in the severely ischemic (25 +/- 5% versus 74 +/- 24%
nonischemic, p = 0.002), moderately ischemic (54 +/- 12% versus 96 +/- 15%
nonischemic, p = 0.001), and mildly ischemic (84 +/- 6% versus 93 +/- 3%
nonischemic, p = 0.002) zones. The defect area defined by 99mTc-MIBI
autoradiography (group 2) correlated very closely with the postmortem
infarct area (rho = 0.98). Thus, the myocardial uptake of 99mTc-MIBI during
coronary occlusion correlates with occlusion flow and reflects the "area at
risk." When 99mTc-MIBI was given after 90 minutes of reperfusion following
3 hours of coronary occlusion, the myocardial activity was significantly
reduced compared with reperfusion flow in both necrotic and perinecrotic
regions, reflecting myocardial viability more than the degree of
reperfusion.
ARTICLES
Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.
This article has been cited by other articles:
![]() |
J. T. Ortiz-Perez, J. Rodriguez, S. N. Meyers, D. C. Lee, C. Davidson, and E. Wu Correspondence Between the 17-Segment Model and Coronary Arterial Anatomy Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 282 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pereztol-Valdes, J. Candell-Riera, C. Santana-Boado, J. Angel, S. Aguade-Bruix, J. Castell-Conesa, E. V. Garcia, and J. Soler-Soler Correspondence between left ventricular 17 myocardial segments and coronary arteries Eur. Heart J., December 2, 2005; 26(24): 2637 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Natanzon, A. H. Aletras, L.-Y. Hsu, and A. E. Arai Determining Canine Myocardial Area at Risk with Manganese-enhanced MR Imaging Radiology, September 1, 2005; 236(3): 859 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Slomka, D. Fieno, L. Thomson, J. D. Friedman, S. W. Hayes, G. Germano, and D. S. Berman Automatic Detection and Size Quantification of Infarcts by Myocardial Perfusion SPECT: Clinical Validation by Delayed-Enhancement MRI J. Nucl. Med., May 1, 2005; 46(5): 728 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ibrahim, S. G. Nekolla, M. Hornke, H. P. Bulow, J. Dirschinger, A. Schomig, and M. Schwaiger Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: Comparison with single-photon emission tomography using Tc99m-sestamibi J. Am. Coll. Cardiol., February 15, 2005; 45(4): 544 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Argaud, G. Rioufol, M. Lievre, L. Bontemps, P. Legalery, M. Stumpf, G. Finet, R. Itti, X. Andre-Fouet, and M. Ovize Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk Eur. Heart J., November 2, 2004; 25(22): 2019 - 2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ndrepepa, J. Mehilli, M. Schwaiger, H. Schuhlen, S. Nekolla, S. Martinoff, C. Schmitt, J. Dirschinger, A. Schomig, and A. Kastrati Prognostic Value of Myocardial Salvage Achieved by Reperfusion Therapy in Patients with Acute Myocardial Infarction J. Nucl. Med., May 1, 2004; 45(5): 725 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Fram, R. R. Azar, A. W. Ahlberg, L. D. Gillam, J. F. Mitchel, F. J. Kiernan, J. A. Hirst, J. F. Mather, E. Ficaro, G. Cyr, et al. Duration of abnormal SPECT myocardial perfusion imaging following resolution of acute ischemia: an angioplasty model J. Am. Coll. Cardiol., February 5, 2003; 41(3): 452 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, G. A. Kastis, G. D. Stevenson, H. H. Barrett, L. R. Furenlid, M. A. Kupinski, D. D. Patton, and D. W. Wilson Quantitative Analysis of Acute Myocardial Infarct in Rat Hearts with Ischemia-Reperfusion Using a High-Resolution Stationary SPECT System J. Nucl. Med., July 1, 2002; 43(7): 933 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Dae, D. W. Gao, D. I. Sessler, K. Chair, and C. A. Stillson Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1584 - H1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwakura, H. Ito, S. Kawano, Y. Shintani, K. Yamamoto, A. Kato, M. Ikushima, K. Tanaka, M. Kitakaze, M. Hori, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction J. Am. Coll. Cardiol., August 1, 2001; 38(2): 472 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sechtem Imaging myocardial area at risk and final infarct size Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C36 - C46. [PDF] |
||||
![]() |
A. Schomig, A. Kastrati, J. Dirschinger, J. Mehilli, U. Schricke, J. Pache, S. Martinoff, F.-J. Neumann, M. Schwaiger, and The Stent versus Thrombolysis for Occluded Coronar Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction N. Engl. J. Med., August 10, 2000; 343(6): 385 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, T. D. Miller, and T. F. Christian Infarct Size Measured by Single Photon Emission Computed Tomographic Imaging With 99mTc-Sestamibi : A Measure of the Efficacy of Therapy in Acute Myocardial Infarction Circulation, January 4, 2000; 101(1): 101 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saeed, J. Bremerich, M. F. Wendland, R. Wyttenbach, H.-J. Weinmann, and C. B. Higgins Reperfused Myocardial Infarction as Seen with Use of Necrosis-specific versus Standard Extracellular MR Contrast Media in Rats Radiology, October 1, 1999; 213(1): 247 - 257. [Abstract] [Full Text] |
||||
![]() |
N. Takahashi, C. P. Reinhardt, R. Marcel, and J. A. Leppo Myocardial Uptake of 99mTc-Tetrofosmin, Sestamibi, and 201Tl in a Model of Acute Coronary Reperfusion Circulation, November 15, 1996; 94(10): 2605 - 2613. [Abstract] [Full Text] |
||||
![]() |
R. Medrano, R. W. Lowry, J. B. Young, D. G. Weilbaecher, L. H. Michael, I. Afridi, Z.-X. He, J. J. Mahmarian, and M. S. Verani Assessment of Myocardial Viability With 99mTc Sestamibi in Patients Undergoing Cardiac Transplantation: A Scintigraphic/Pathological Study Circulation, September 1, 1996; 94(5): 1010 - 1017. [Abstract] [Full Text] |
||||
![]() |
G. L. Schaer, L. J. Spaccavento, K. F. Browne, K. A. Krueger, D. Krichbaum, J. M. Phelan, W. O. Fletcher, C. L. Grines, S. Edwards, M. K. Jolly, et al. Beneficial Effects of RheothRx Injection in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction: Results of a Randomized, Double-Blind, Placebo-Controlled Trial Circulation, August 1, 1996; 94(3): 298 - 307. [Abstract] [Full Text] |
||||
![]() |
V. Sansoy, D. K. Glover, D. D. Watson, M. Ruiz, W. H. Smith, J. P. Simanis, and G. A. Beller Comparison of Thallium-201 Resting Redistribution With Technetium-99m–Sestamibi Uptake and Functional Response to Dobutamine for Assessment of Myocardial Viability Circulation, August 15, 1995; 92(4): 994 - 1004. [Abstract] [Full Text] |
||||
![]() |
T. D. Miller, T. F. Christian, M. R. Hopfenspirger, D. O. Hodge, B. J. Gersh, and R. J. Gibbons Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99mTc Sestamibi Imaging Predicts Subsequent Mortality Circulation, August 1, 1995; 92(3): 334 - 341. [Abstract] [Full Text] |
||||
![]() |
R. J. Gibbons, D. R. Holmes, G. S. Reeder, K. R. Bailey, M. R. Hopfenspirger, B. J. Gersh, and The Mayo Coronary Care Unit and Catheterization La Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 685 - 691. [Abstract] [Full Text] |
||||
![]() |
H. Matsuo, S. Watanabe, T. Kadosaki, T. Yamaki, S. Tanaka, S. Miyata, T. Segawa, Y. Matsuno, M. Tomita, and H. Fujiwara Validation of Collateral Fractional Flow Reserve by Myocardial Perfusion Imaging Circulation, March 5, 2002; 105(9): 1060 - 1065. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |